The CellSearch system, as an approved method to test CTCs, depends on the expression of EpCAM and greatly limited the positive rate of CTCs in some epithelium-originated solid tumors like breast cancer and pancreatic cancer [33,34] for the reason that the expression of EpCAM was reduced during EMT. Here, EPCAM is linked to familial pancreatic carcinoma.